Table 3.

Antibiotic susceptibilities expressed as proportions of Gram-negative bacilli without (no MDR) and with MDR profile

	AMC		TZP		IMP		CTX		CAZ		GEN		AMK		CIP		LVX
	No MDR	MDR	No MDR	MDR	No MDR	MDR	No MDR	MDR	No MDR	MDR	No MDR	MDR	No MDR	MDR	No MDR	MDR	No MDR	MDR
Enterobacterales (n = 426)	68	5	99	38	100	97	99	55	100	64	99	77	99	91	100	86	98	71
Escherichia coli (n = 200)	82	7	100	60	100	98	100	85	100	88	100	81	99	99	100	96	97	73
Klebsiella spp. (n = 59)	85	5	95	21	100	94	100	37	100	39	100	39	100	74	100	63	100	56
Enterobacter spp. (n = 78)	–	–	100	5	100	97	93	5	100	10	96	79	100	79	100	65	97	70
Other Enterobacterales (n = 89)	75	0	100	23	100	100	100	31	100	40	100	69	99	85	100	86	100	83
Non-fermenting GNB (n = 73)	–	–	88	38	81	46	–	–	93	48	58	19	93	78	95	32	–	–
Pseudomonas aeruginosa (n = 65)	–	–	93	42	90	50	–	–	100	53	60	23	98	86	95	33	–	–

AMC Amoxicillin/clavulanic acid, TZP Piperacillin/tazobactam, IMP Imipenem/cilastatin, CTX Cefotaxime, CAZ Ceftazidime, GEN Gentamicin, AMK Amikacin, CIP Ciprofloxacin, LVX Levofloxacin